Drug Discovery News and Research

RSS

The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.

Why new cancer drugs take so long to reach the market

A new analysis of cancer drug development by researchers at the Institute of Cancer Research, London, shows that the more revolutionary a new cancer drug is, the longer it takes to reach patients in the UK’s National Health Service healthcare system. In other words, refinements on earlier drugs or drugs which are more conventional in their effects make it to the marketplace faster

28 Jan 2020

Researchers solve long-standing mystery linked to contraction of heart cells

We've all felt the effects of an adrenaline rush. Faced with danger, real or perceived, the heart beats faster, breathing quickens and muscles tighten as the body prepares to fight a threat or flee from it.

23 Jan 2020

Carterra closes financing round for continued growth of the LSA platform for next generation antibody discovery

Carterra Inc., the world leader in high-throughput antibody screening and characterization, has closed a $6M round of financing led by Ballast Point Ventures with participation from current investor, Telegraph Hill Partners.

From Carterra Inc. 23 Jan 2020

Nicoya raises $10 million in series a funding to make drug discovery digital

Nicoya, a leading provider of advanced analytical instruments for the biotechnology and pharmaceutical industries, announced today that it has raised $10 million in Series A financing.

From Nicoya Lifesciences 23 Jan 2020

Patient-specific tumor organoids may one day be used to personalize cancer treatment

A patient-specific tumor organoid platform developed by Wake Forest Institute for Regenerative Medicine researchers and their cancer center colleagues could someday take the guessing game out of immunotherapy treatments.

21 Jan 2020

New technology systematically identifies drug targets in living animals

Developing new medicines and understanding how they target specific organs often gives a crucial advantage in the fight against human diseases.

21 Jan 2020

Turbine appoints new SAB members to guide its simulation-first drug discovery mission

Turbine, a simulation-first drug discovery company, today announced the formation of its Scientific Advisory Board with the appointments of Dr. Annalisa Jenkins, Dr. Mihriban Tuna, and Dr. Alan Barge.

21 Jan 2020

Enterprise Therapeutics publishes open access paper on novel approach to treat cystic fibrosis

Enterprise Therapeutics Ltd, a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients suffering with respiratory disease, today announced the publication of its first peer-reviewed paper.

21 Jan 2020

UCR receives $2.2 million grant to target critical oncogenes of B-cell lymphoma 2

One way to tackle cancer, the second-leading cause of death in the United States, is to target oncogenes -- genes that have the potential to cause cancer.

17 Jan 2020

New method for detection of microcystins and nodularin in human urine

Blooms of toxin-producing algae exploded in both fresh and salt water ecosystems in southern Florida during the summer months of 2018, impacting wildlife and humans living in these marine environments.

16 Jan 2020

Nicoya gains series A funding for digital drug discovery program

Nicoya, a leading provider of advanced analytical instruments for the biotechnology and pharmaceutical industries, announced today that it has raised $10 million in Series A financing.

From Nicoya Lifesciences 15 Jan 2020

Mayo Clinic launches Clinical Data Analytics Platform to improve the health of patients

Mayo Clinic announced the Clinical Data Analytics Platform as the first venture under the Mayo Clinic Platform, a strategic initiative to improve health care through insights and knowledge derived from data.

14 Jan 2020

How SpatialOMx is Delivering New Insights into Disease Research

An interview with Shannon Cornett Ph.D, discussing the use of MALDI-guided spatial molecular analysis for biomarker discovery.

From Bruker Life Sciences Mass Spectrometry 14 Jan 2020

Insilico Medicine to showcase results of generative biology target ID system

Insilico Medicine, a biotechnology company developing end-to-end drug discovery pipelines utilizing the next-generation artificial intelligence, to present new results of its generative biology pipeline resulting in novel targets in liver disease.

12 Jan 2020

Pathios appoints Stuart Hughes as CEO and announces US$8.8M Series A financing round

Pathios Therapeutics Limited, an innovative biotech company focused on the development of first-in-class therapies for autoimmune diseases and cancer, today announced a US$8.8M Series A financing round with leading international healthcare investors Canaan and Australia’s Medical Research Commercialization Fund managed by Brandon Capital.

9 Jan 2020

Insilico and Beiersdorf use next-generation AI technology in skin research

Beiersdorf and Insilico Medicine, an artificial intelligence company developing end to end drug discovery pipelines, announced today that they are entering a collaboration to jointly discover novel, safe bioactive ingredients for a specific skin indication at an unparalleled pace, that will serve as the basis for developing appropriate skincare products.

8 Jan 2020

Boehringer Ingelheim to use PhoreMost's SITESEEKER platform in new collaboration

PhoreMost to deploy its SITESEEKER platform to identify novel targets for Boehringer Ingelheim’s discovery programs.

From PhoreMost 7 Jan 2020

Structure of most lethal toxin produced by C. difficile bacteria identified

Researchers from the University of Maryland School of Medicine and their colleagues have identified the structure of the most lethal toxin produced by certain strains of Clostridium difficile bacteria, a potentially deadly infection associated with the use of antibiotics. The

2 Jan 2020

Scientists discover potential drug compounds that target common type of liver cancer

Scientists from the Cancer Science Institute of Singapore at the National University of Singapore, and the Agency for Science, Technology and Research (A*STAR)'s Genome Institute of Singapore have discovered four potential drug compounds that target hepatocellular carcinoma, the most common type of liver cancer.

30 Dec 2019

New 'tumor-on-a-chip' can be used to find better cancer fighting drugs

Kyoto University researchers have developed a new 'tumor-on-a-chip' device that can better mimic the environment inside the body, paving the way for improved screening of potential cancer-fighting drugs.

20 Dec 2019

Drug Discovery News and Research

Further Reading

Why new cancer drugs take so long to reach the market

Researchers solve long-standing mystery linked to contraction of heart cells

Carterra closes financing round for continued growth of the LSA platform for next generation antibody discovery

Nicoya raises $10 million in series a funding to make drug discovery digital

Patient-specific tumor organoids may one day be used to personalize cancer treatment

New technology systematically identifies drug targets in living animals

Turbine appoints new SAB members to guide its simulation-first drug discovery mission

Enterprise Therapeutics publishes open access paper on novel approach to treat cystic fibrosis

UCR receives $2.2 million grant to target critical oncogenes of B-cell lymphoma 2

New method for detection of microcystins and nodularin in human urine

Nicoya gains series A funding for digital drug discovery program

Mayo Clinic launches Clinical Data Analytics Platform to improve the health of patients

How SpatialOMx is Delivering New Insights into Disease Research

Insilico Medicine to showcase results of generative biology target ID system

Pathios appoints Stuart Hughes as CEO and announces US$8.8M Series A financing round

Insilico and Beiersdorf use next-generation AI technology in skin research

Boehringer Ingelheim to use PhoreMost's SITESEEKER platform in new collaboration

Structure of most lethal toxin produced by C. difficile bacteria identified

Scientists discover potential drug compounds that target common type of liver cancer

New 'tumor-on-a-chip' can be used to find better cancer fighting drugs

ELRIG Drug Discovery: Poster Sessions eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News